FRA:7XE (Finland)
Â
Ordinary Shares - Series B
€
0.75
-0.028 (-3.66%)
Sep 21
Business Description
Nightingale Health PLC
SIC : 8731
ISIN : FI4000490875
Share Class Description:
FRA:7XE: Ordinary Shares - Series BTotal Employee Number:
103Compare
Compare
Traded in other countries / regions
HEALTH.Finland7XE.GermanyNGHLF.USA IPO Date
2021-03-26Description
Nightingale Health PLC is a Finnish preventive health and biotechnology company that provides blood-based biomarker analysis and disease risk assessment services. Its core technology uses nuclear magnetic resonance (NMR) spectroscopy to measure hundreds of metabolic biomarkers from a single blood sample, generating a detailed metabolic profile that can indicate risk for conditions such as cardiovascular disease, type 2 diabetes, and kidney disease. The company offers its blood testing and risk analysis platform to healthcare providers, employers, insurers, research institutions, and biobanks, as well as directly to consumers through health screening services. It also collaborates with research and pharmaceutical partners on large-scale population studies. Nightingale operates primarily in Finland and has expanded into international markets including Japan, the United Kingdom, Singapore, and the United States. Revenue is generated through biomarker analysis services, platform licensing, and partnership agreements with healthcare and research organizations.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 8.76 | |||||
Equity-to-Asset | 0.87 | |||||
Debt-to-Equity | 0.08 | |||||
Debt-to-EBITDA | -0.46 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 2.59 | |||||
Beneish M-Score | -3.36 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 27.1 | |||||
3-Year EBITDA Growth Rate | 3.5 | |||||
3-Year EPS without NRI Growth Rate | -9.5 | |||||
3-Year FCF Growth Rate | 1.9 | |||||
3-Year Book Growth Rate | -16 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 14.56 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 39.93 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 21.39 | |||||
9-Day RSI | 32.03 | |||||
14-Day RSI | 39.26 | |||||
3-1 Month Momentum % | 16.67 | |||||
6-1 Month Momentum % | -39.6 | |||||
12-1 Month Momentum % | -67.06 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 8.53 | |||||
Quick Ratio | 8.19 | |||||
Cash Ratio | 7.79 | |||||
Days Inventory | 380 | |||||
Days Sales Outstanding | 105.18 | |||||
Days Payable | 565.11 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 67.37 | |||||
Operating Margin % | -397 | |||||
Net Margin % | -397.69 | |||||
EBITDA Margin % | -221.62 | |||||
FCF Margin % | -268.41 | |||||
OCF Margin % | -216.78 | |||||
ROE % | -28.64 | |||||
ROA % | -25.71 | |||||
ROIC % | -87.32 | |||||
3-Year ROIIC % | 64.07 | |||||
ROC (Joel Greenblatt) % | -182.7 | |||||
ROCE % | -26.16 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 10.74 | |||||
PB Ratio | 0.89 | |||||
Price-to-Tangible-Book | 1.03 | |||||
EV-to-EBIT | -1.15 | |||||
EV-to-EBITDA | -1.92 | |||||
EV-to-Revenue | 4.3 | |||||
EV-to-FCF | -1.16 | |||||
Price-to-GF-Value | 0.25 | |||||
| Price-to-Net-Current-Asset-Value | 1.34 | |||||
| Price-to-Net-Cash | 1.51 | |||||
Earnings Yield (Greenblatt) % | -87.21 | |||||
FCF Yield % | -28.67 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nightingale Health PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 4.796 | ||
| EPS (TTM) (€) | -0.316 | ||
| Beta | -0.7603 | ||
| 3-Year Sharpe Ratio | 0.26 | ||
| 3-Year Sortino Ratio | 0.63 | ||
| Volatility % | 41.26 | ||
| 14-Day RSI | 39.26 | ||
| 14-Day ATR (€) | 0.014643 | ||
| 20-Day SMA (€) | 0.7879 | ||
| 12-1 Month Momentum % | -67.06 | ||
| 52-Week Range (€) | 0.672 - 2.56 | ||
| Shares Outstanding (Mil) | 60.36 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nightingale Health PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nightingale Health PLC Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Second quarter earnings conference call for 2027 | 2027-03-05 14:00 | In 165 days | ||
| Second quarter earnings results for 2027 | 2027-03-05 | In 164 days | ||
| General meeting for 2026 | 2026-11-06 15:00 | In 46 days | ||
| Annual report for 2026 | 2026-10-02 | In 10 days | ||
| Fourth quarter earnings conference call for 2026 | 2026-09-18 14:00 | 0.77 (+0.00%) | ||
| Fourth quarter earnings results for 2026 | 2026-09-18 | 0.77 (+0.00%) | ||
| Second quarter earnings conference call for 2026 | 2026-03-05 14:00 | 1.31 (+0.00%) | ||
| Second quarter earnings results for 2026 | 2026-03-05 | 1.31 (+0.00%) | ||
| General meeting for 2025 | 2025-11-06 15:00 | 2.22 (+0.00%) | ||
| Annual report for 2025 | 2025-10-02 | 2.20 (+0.00%) |
Show
Entries
Nightingale Health PLC Frequently Asked Questions
What is Nightingale Health PLC(FRA:7XE)'s stock price today?
The current price of FRA:7XE is €0.75. The 52 week high of FRA:7XE is €2.56 and 52 week low is €0.67.
When is next earnings date of Nightingale Health PLC(FRA:7XE)?
The next earnings date of Nightingale Health PLC(FRA:7XE) is 2027-03-05 Est..
Does Nightingale Health PLC(FRA:7XE) pay dividends? If so, how much?
Nightingale Health PLC(FRA:7XE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers